Immunisation programmes are foundational to public health. Organised by health authorities, they systematically deliver ...

OHE’s BRAVER Roadmap outlines how adopting a societal perspective in HTA can improve equity, innovation, and health outcomes ...

As part of EuroQol’s current priority-setting work, the development of bolt-ons for the EQ-5D-5L instrument has taken centre stage. A “bolt-on toolbox” is being developed to identify and test ...

Neil McAuslane PhD, MSc, BSc. Scientific Director of the Centre for Innovation in Regulatory Science (CIRS) overseeing the scientific content of both CIRS regulatory and HTA programmes. Key research ...

Dr Richard Torbett joined ABPI in July 2015 and previously held the role of Executive Director of Economic, Health and Commercial Policy. In this role, Richard was responsible for pricing policy ...

In this Insights series, Around the World in HTAs, we shed light on HTA around the world. In this edition, Adam Raymakers and Chris Skedgel take us to Canada. Canada has a universal single-payer ...

Pedro Pita Barros is the BPI | Fundação “la Caixa” Professor of Health Economics at Nova School of Business and Economics, Universidade Nova de Lisboa. He holds a PhD in Economics and his research ...

Patrick Holmes is an industry veteran with over 30 years of experience in the pharmaceutical industry in a broad range of roles, most notably in the global policy arena. Patrick is the Science and ...

Alastair Fischer Ph.D. has had a long career in statistics, economics and public health. He has a BSc from the University of Adelaide majoring in Pure Mathematica and Statistics, a BEc from the ...

As Vice Provost (Strategic Research Partnerships) at SMU, Dr Cheong develops multi-disciplinary, strategic research partnerships with government and industry, to advance the international standing of ...